Author's reply to Borg et al. Comment on: "EU's new pharmacovigilance legislation: Considerations for biosimilars"

ISSN: 1179-1942,  0114-5916

Year of publication: 2014

Volume: 37

Issue: 2

Pages: 125-126

Type: Letter